Clinical Trials Logo

Neoplasms by Site clinical trials

View clinical trials related to Neoplasms by Site.

Filter by:

NCT ID: NCT01043913 Completed - Neoplasms Clinical Trials

Guarana (Paullinia Cupana) for Breast Cancer Chemotherapy-related Fatigue

Start date: February 2008
Phase: Phase 2
Study type: Interventional

The investigators hypothesize that Guaraná, a native plant from the Amazon, might improve chemotherapy-induced fatigue in breast cancer patients undergoing treatment. In order to assess this, the investigators randomized patients to either guaraná extract or to placebo, switching the assigned treatment mid-term through the cycles of Chemotherapy.

NCT ID: NCT01037049 Active, not recruiting - Neoplasms Clinical Trials

Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks

Start date: October 16, 2009
Phase: Phase 2
Study type: Interventional

The aim of this study is to determine whether greater rectal cancer downstaging and regression occurs when surgery is delayed to 12 weeks after completion of radiotherapy/chemotherapy compared to 6 weeks. Hypothesis: Greater downstaging and tumour regression is observed when surgery is delayed to 12 weeks after completion of CRT compared to 6 weeks.

NCT ID: NCT01009593 Terminated - Neoplasms Clinical Trials

Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)

Start date: January 2010
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to assess the overall survival (OS) of oral linifanib given as monotherapy once daily (QD) compared to sorafenib given twice daily (BID) per standard of care in subjects with advanced or metastatic HCC.

NCT ID: NCT00562224 Completed - Multiple Myeloma Clinical Trials

Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients

Start date: November 2007
Phase: Phase 1
Study type: Interventional

To determine the highest dose of study drug that can be taken without causing serious side effects in patients with advanced cancer. The study will look at safety of the study drug and whether the treatment schedule is tolerated by patients.

NCT ID: NCT00384891 Terminated - Neoplasms Clinical Trials

Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer

Start date: February 2002
Phase: Phase 3
Study type: Interventional

The study is designed to compare the efficacy and safety of 2 treatment types for the prevention of tumor recurrence of superficial bladder cancer: 1. A combination of bladder wall heating and local chemotherapy (Synergo) 2. Bacillus Calmette-Guérin (BCG)

NCT ID: NCT00377520 Completed - Neoplasms Clinical Trials

A Trial for Patients With Advanced/Recurrent Endometrial Cancer

Start date: September 2006
Phase: Phase 2
Study type: Interventional

The intent of this protocol is to screen a new agent for activity in patients with advanced or recurrent endometrial carcinoma. This phase II trial is studying how well pemetrexed disodium works in treating patients with advanced or recurrent endometrial carcinoma.

NCT ID: NCT00341692 Completed - Neoplasms Clinical Trials

Studying Normal Breast Tissue and Cancer Risk

Start date: April 7, 2003
Phase:
Study type: Observational

Breast cancer is the most common cancer among women in the United States. Breast cancer research has been hampered by the difficulty in collecting normal breast tissue. In this study, researchers will obtain samples of normal breast tissue from organ donors and will collect risk-factor data from next-of-kin. The purpose of this study is to learn how normal breast develops and responds to stresses that are known to increase a woman s chance of developing breast cancer. Following the breast-tissue donation from 20 volunteers, surgical technicians will make small incisions in the skin and tissue of the breast and remove several samples measuring about one-inch. Technicians also will take samples of the uterine lining to estimate the date of the last menstrual period. The tissue will then be sent to the National Cancer Institute for laboratory research studies. Steps will be taken to ensure that the identity of the participants remains confidential.

NCT ID: NCT00050427 Completed - Neoplasms Clinical Trials

A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer

Start date: December 2002
Phase: Phase 2
Study type: Interventional

The purpose of this study is to test the safety and effectiveness of an investigational chemotherapy agent in patients with advanced breast cancer.

NCT ID: NCT00050414 Completed - Neoplasms Clinical Trials

A Study of Trabectedin in Patients With Advanced Ovarian Cancer

Start date: October 2002
Phase: Phase 2
Study type: Interventional

The purpose of this study is to test the safety and effectiveness of an investigational chemotherapy agent in patients with advanced ovarian cancer.